Croda Executives Acquire Shares Under Company Incentive Plan

The latest announcement is out from Croda International ( (GB:CRDA) ).

Croda International has disclosed that several persons discharging managerial responsibilities, including Executive Director Stephen Foots and other senior executives, have acquired ordinary shares in the company through its Share Incentive Plan. On 12 January 2026, the plan trustee purchased partnership shares and awarded matching shares on behalf of six senior managers at a price of 2,714p per share, with the aggregated cost per share reported as 1,357p, signalling ongoing executive participation in the company’s equity-based remuneration scheme and reinforcing alignment between management and shareholder interests.

The most recent analyst rating on (GB:CRDA) stock is a Hold with a £2914.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.

Spark’s Take on GB:CRDA Stock

According to Spark, TipRanks’ AI Analyst, GB:CRDA is a Neutral.

Croda International’s overall stock score reflects a mix of solid financial health and strategic initiatives, tempered by valuation concerns and technical weaknesses. The company’s strong earnings call and positive corporate events provide a supportive backdrop, but investors should be cautious of the high P/E ratio and bearish technical indicators.

To see Spark’s full report on GB:CRDA stock, click here.

More about Croda International

Croda International is a UK-based specialty chemicals company that manufactures and supplies high-value ingredients and technologies used across sectors such as personal care, life sciences and performance technologies. Its products are typically sold to industrial and consumer-goods manufacturers, and the company is listed on the London Stock Exchange.

Average Trading Volume: 651,999

Technical Sentiment Signal: Sell

Current Market Cap: £3.76B

Find detailed analytics on CRDA stock on TipRanks’ Stock Analysis page.